1. Home
  2. BRNS vs SNAL Comparison

BRNS vs SNAL Comparison

Compare BRNS & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRNS
  • SNAL
  • Stock Information
  • Founded
  • BRNS 2016
  • SNAL 2000
  • Country
  • BRNS United Kingdom
  • SNAL United States
  • Employees
  • BRNS N/A
  • SNAL N/A
  • Industry
  • BRNS Biotechnology: Pharmaceutical Preparations
  • SNAL Computer Software: Prepackaged Software
  • Sector
  • BRNS Health Care
  • SNAL Technology
  • Exchange
  • BRNS Nasdaq
  • SNAL Nasdaq
  • Market Cap
  • BRNS 40.0M
  • SNAL 40.0M
  • IPO Year
  • BRNS 2021
  • SNAL 2022
  • Fundamental
  • Price
  • BRNS $0.92
  • SNAL $1.42
  • Analyst Decision
  • BRNS Strong Buy
  • SNAL
  • Analyst Count
  • BRNS 1
  • SNAL 0
  • Target Price
  • BRNS $3.00
  • SNAL N/A
  • AVG Volume (30 Days)
  • BRNS 18.8K
  • SNAL 74.4K
  • Earning Date
  • BRNS 08-07-2025
  • SNAL 08-12-2025
  • Dividend Yield
  • BRNS N/A
  • SNAL N/A
  • EPS Growth
  • BRNS N/A
  • SNAL N/A
  • EPS
  • BRNS N/A
  • SNAL 0.04
  • Revenue
  • BRNS $14,969,000.00
  • SNAL $90,462,190.00
  • Revenue This Year
  • BRNS N/A
  • SNAL $24.50
  • Revenue Next Year
  • BRNS N/A
  • SNAL $20.27
  • P/E Ratio
  • BRNS N/A
  • SNAL $37.23
  • Revenue Growth
  • BRNS 4381.74
  • SNAL 46.95
  • 52 Week Low
  • BRNS $0.64
  • SNAL $0.52
  • 52 Week High
  • BRNS $1.58
  • SNAL $3.42
  • Technical
  • Relative Strength Index (RSI)
  • BRNS 50.69
  • SNAL 63.17
  • Support Level
  • BRNS $0.83
  • SNAL $1.25
  • Resistance Level
  • BRNS $0.95
  • SNAL $1.83
  • Average True Range (ATR)
  • BRNS 0.05
  • SNAL 0.19
  • MACD
  • BRNS -0.01
  • SNAL 0.02
  • Stochastic Oscillator
  • BRNS 45.35
  • SNAL 51.76

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

About SNAL Snail Inc.

Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.

Share on Social Networks: